Depression in relapsing-remitting multiple sclerosis

被引:24
|
作者
Mendes, MF [1 ]
Tilbery, CP [1 ]
Balsimelli, S [1 ]
Moreira, MA [1 ]
Barao-Cruz, AM [1 ]
机构
[1] Fac Ciencias Med Santa Casa Sao Paulo, Dept Med, Disciplina Neurol, Ctr Atendimento & Tratamento Esclerose Miltipla, Sao Paulo, Brazil
关键词
depression; multiple sclerosis; disability; EDSS;
D O I
10.1590/S0004-282X2003000400012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The suggestion of a possible relationship between depression and multiple sclerosis (MS) has existed for many years, and the prevalence studies are believed by potential biases. In our country, the prevalence of clinical depression in patients with VIS is unknown. The objective of the present study was to ascertain the rate of depression in a group of MS patients and to analyze the relationship to depression, disability, gender, age and duration of illness. We evaluated 84 relapsing-remitting MS patients using the Beck Scale (BS), the Hospital Anxiety and Depression scale (HAD) and the Expanded Disability Status Scale (EDSS). The depression was presented at 17.9% and the anxiety at 34.5% of the RRMS patients. There is a correlation between depression and functional disability (p=0.0002), but there is no relation between depression and sex, age or duration of the illness. This analysis confirms that depression is common in persons with MS and suggests the association with functional disability.
引用
收藏
页码:591 / 595
页数:5
相关论文
共 50 条
  • [1] Prevalence of Depression in Patients with Relapsing-remitting Multiple Sclerosis
    Iranmanesh, F.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (04) : 523 - 523
  • [2] Relapsing-remitting multiple sclerosis
    Flores, A
    Ochoa, E
    Zamora, S
    Barrientos, UN
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
  • [3] Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis
    Rossi, S.
    Studer, V.
    Motta, C.
    Polidoro, S.
    Chiarello, E.
    Gelibter, S.
    Calo, A.
    Colonna, I.
    Centonze, D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 712 - 712
  • [4] Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis
    Rossi, Silvia
    Studer, Valeria
    Motta, Caterina
    Polidoro, Serena
    Perugini, Jacopo
    Macchiarulo, Giulia
    Giovannetti, Ambra Mara
    Pareja-Gutierrez, Lorena
    Calo, Andrea
    Colonna, Isabella
    Furlan, Roberto
    Martino, Gianvito
    Centonze, Diego
    [J]. NEUROLOGY, 2017, 89 (13) : 1338 - 1347
  • [5] Autohemotherapy for relapsing-remitting multiple sclerosis
    Mubaidin, AF
    Horani, KA
    Dehayyat, MA
    Shehab, M
    Abu-Ruman, IA
    Shurbaji, AA
    Kurdi, A
    Hiari, M
    Khakish, M
    Harahsheh, O
    Dabbas, M
    [J]. NEUROLOGY, 2001, 56 (08) : A75 - A75
  • [6] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Guo, Rui
    Zhang, Fubo
    Zhang, Chao
    Dong, Shuai
    Zhou, Hongyu
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [7] Relapsing-remitting tumefactive multiple sclerosis
    Selkirk, SM
    Shi, J
    [J]. MULTIPLE SCLEROSIS, 2005, 11 (06): : 731 - 734
  • [8] Rituximab in relapsing-remitting multiple sclerosis
    Schrijver, Hans M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24): : 2645 - 2645
  • [9] Fingolimod for relapsing-remitting multiple sclerosis
    La Mantia, Loredana
    Tramacere, Irene
    Firwana, Belal
    Pacchetti, Ilaria
    Palumbo, Roberto
    Filippini, Graziella
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [10] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481